ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,297.10
-0.21%
Dow Jones
39,869.38
0.00%
US Dollar vs MXN
16.6808
0.00%
Brent Oil
83.095
-0.13%
Bitcoin
66,314.66
1.65%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Regeneron Pharmaceuticals Inc (0R2M)

  7. Regeneron Pharmaceuticals Inc (0R2M) Noticias

0R2M

Regeneron Pharmaceuticals (0R2M)

Regeneron Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:0R2M
FechaHoraFuenteTítuloSímboloCompañía
26/01/202415:07Alliance NewsAlliance NewsSanofi and Regeneron celebrate Dupixent's FDA approvalLSE:0R2MRegeneron Pharmaceuticals Inc
11/12/202313:25Alliance NewsAlliance NewsLeading pharmaceutical firms highlight positive trial data on lymphomaLSE:0R2MRegeneron Pharmaceuticals Inc
15/09/202223:46Alliance NewsAlliance NewsRegeneron, Sanofi drug effective for young children with severe eczemaLSE:0R2MRegeneron Pharmaceuticals Inc
09/09/202200:40Alliance NewsAlliance NewsRegeneron shares surge on positive Eylea trial dataLSE:0R2MRegeneron Pharmaceuticals Inc
02/06/202209:18Alliance NewsAlliance NewsSanofi grants Regeneron global license for cancer treatment LibtayoLSE:0R2MRegeneron Pharmaceuticals Inc
31/05/202200:54Alliance NewsAlliance NewsUS FDA accepts Regeneron and Sanofi's Dupixent for priority reviewLSE:0R2MRegeneron Pharmaceuticals Inc
28/03/202200:18Alliance NewsAlliance NewsIN BRIEF: Sanofi, Regeneron hail positive results in prurigo nodularisLSE:0R2MRegeneron Pharmaceuticals Inc
28/02/202200:21Alliance NewsAlliance NewsSanofi and Regeneron note positive new data for DupixentLSE:0R2MRegeneron Pharmaceuticals Inc
18/02/202204:26Alliance NewsAlliance NewsRegeneron and Sanofi stop trial of skin condition treatment DupixentLSE:0R2MRegeneron Pharmaceuticals Inc
19/01/202201:32Alliance NewsAlliance NewsSanofi and Regeneron's Dupixent meets endpoints for skin treatmentLSE:0R2MRegeneron Pharmaceuticals Inc
12/11/202109:54Alliance NewsAlliance NewsTOP NEWS: Roche and Regeneron Covid antibody cocktail approved in EULSE:0R2MRegeneron Pharmaceuticals Inc
25/10/202100:50Alliance NewsAlliance NewsSanofi and Regeneron's Dupixent trial meets primary endpointsLSE:0R2MRegeneron Pharmaceuticals Inc
14/10/202107:18Alliance NewsAlliance NewsUS FDA accepts Regeneron's REGEN-COV application for priority reviewLSE:0R2MRegeneron Pharmaceuticals Inc
30/09/202100:36Alliance NewsAlliance NewsRegeneron, Roche drug cocktail reduces Covid-19 viral load - UK studyLSE:0R2MRegeneron Pharmaceuticals Inc
30/08/202101:23Alliance NewsAlliance NewsSanofi, Regeneron's Dupixent works for children with atopic dermatitisLSE:0R2MRegeneron Pharmaceuticals Inc
27/07/202106:56Alliance NewsAlliance NewsAstraZeneca partners with Regeneron to research obesity treatmentLSE:0R2MRegeneron Pharmaceuticals Inc
20/07/202100:58Alliance NewsAlliance NewsRoche and Regeneron's Covid antibody cocktail gets Japan approvalLSE:0R2MRegeneron Pharmaceuticals Inc
28/06/202100:16Alliance NewsAlliance NewsSanofi, Regeneron report well-established safety profile of DupixentLSE:0R2MRegeneron Pharmaceuticals Inc
25/06/202100:48Alliance NewsAlliance NewsSanofi and Regeneron's cancer treatment Libtayo gets approval in EULSE:0R2MRegeneron Pharmaceuticals Inc
23/03/202102:26Alliance NewsAlliance NewsTOP NEWS: Novartis, Regeneron Covid antibody cocktail excels in trialsLSE:0R2MRegeneron Pharmaceuticals Inc
15/03/202104:20Alliance NewsAlliance NewsRegeneron, Sanofi report positive phase three trial results of LibtayoLSE:0R2MRegeneron Pharmaceuticals Inc
26/02/202111:25Alliance NewsAlliance NewsEU Medicines Regulator Approves Regeneron Coronavirus TherapyLSE:0R2MRegeneron Pharmaceuticals Inc
25/02/202108:05Alliance NewsAlliance NewsRoche, Regeneron Note Positive Findings For REGEN-COV In Covid-19LSE:0R2MRegeneron Pharmaceuticals Inc
22/02/202114:13Alliance NewsAlliance NewsIN BRIEF: Sanofi, Regeneron Get US FDA Approval For Lung Cancer DrugLSE:0R2MRegeneron Pharmaceuticals Inc
13/01/202100:24Alliance NewsAlliance NewsRoche Says US To Buy Extra Doses Of Regeneron's Covid Antibody CoctailLSE:0R2MRegeneron Pharmaceuticals Inc
01/12/202016:27Alliance NewsAlliance NewsRegeneron Pharmaceuticals Developing Nasal Spray To Prevent Covid-19LSE:0R2MRegeneron Pharmaceuticals Inc
30/11/202003:59Alliance NewsAlliance NewsSanofi And Regeneron Announce New Dupixent Approval In ChildrenLSE:0R2MRegeneron Pharmaceuticals Inc
26/10/202007:52Alliance NewsAlliance NewsSanofi, Regeneron Say Dupixent Lowers Esophagitis SymptomsLSE:0R2MRegeneron Pharmaceuticals Inc
16/10/202008:19Alliance NewsAlliance NewsSanofi And Regeneron Get European Boost For DupixentLSE:0R2MRegeneron Pharmaceuticals Inc
13/10/202000:35Alliance NewsAlliance NewsSanofi And Regeneron Say Dupixent Significantly Reduces Asthma AttacksLSE:0R2MRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:LSE:0R2M

Su Consulta Reciente

NASDAQ
ANCC
Airnet Communications
AMEX
APRP
PGIM US Large Cap Buffer...
EU
0222T
0222T
COIN
ASCCUST
LSE
XU15
Citi Fun 28
BIT
F39647
Vontobel Financial Produ...
EU
ESGTL
ESG LD TRANSATL D
TSXV
MEGO.P
Amego Capital
TSXV
ETF
Eastfield Resources
BIT
F20847
Vontobel Financial Produ...
ASX
ETPMAG
Global X Metal Securitie...
LSE
XT24
Citi Fun 25
NASDAQ
AAZCPXX
Bofa Finance Llc Autocal...
LSE
51QB
Lukoil Int. 26s
BIT
F05829
Vontobel Financial Produ...
BOV
BCRI11
Banestes Recebiveis Imob...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados